TNFR1/Fas engagement results in the cleavage of cytosolic Bid to truncated Bid (tBid), which translocates to mitochondria. We demonstrate that recombinant tBid induces in vitro immediate destabilization of the mitochondrial bioenergetic homeostasis. These alterations result in mild uncoupling of mitochondrial state-4 respiration, associated with an inhibition the adenosine diphosphate (ADP)-stimulated respiration and phosphorylation rate. tBid disruption of mitochondrial homeostasis was inhibited in mitochondria overexpressing Bcl-2 and Bcl-XL. The inhibition of state-3 respiration is mediated by the reorganization of cardiolipin within the mitochondrial membranes, which indirectly affects the activity of the ADP/ATP translocator. Cardiolipin-deficient yeast mitochondria did not exhibit any respiratory inhibition by tBid, proving the absolute requirement for cardiolipin for tBid binding and activity. In contrast, the wild-type yeast mitochondria underwent a similar inhibition of ADP-stimulated respiration associated with reduced ATP synthesis. These events suggest that mitochondrial lipids rather than proteins are the key determinants of tBid-induced destabilization of mitochondrial bioenergetics.
Introduction
During the past decade, it has become unequivocally clear that most proapoptotic stimuli require a mitochondrialdependent step, involving disruption of mitochondrial bioenergetics 1,2 (and for reviews, see Kroemer et al., 3 Wang 4 and Newmeyer et al.
5
) and outer membrane permeabilization. [6] [7] [8] Proapoptotic proteins of the Bcl-2 family regulate the pathways of apoptosis that induce the release of apoptogenic factors from the mitochondrial intermembrane space 9 such as cytochrome c. Cytochrome c is normally involved in the electron transfer from the bc1 complex (complex III) to cytochrome oxidase (complex IV). Once released into the cytosol, cytochrome c activates the caspase cascade by inducing the oligomerization of a cytochrome c dATP/Apaf-1/ pro-caspase-9 complex named apoptosome.
Moreover, it was recently reported that changes of mitochondrial physiology appeared during many apoptotic pathways 10 and could be induced by many pro-and antiapoptotic factors. Although the ability of Bcl-Xl and Bcl-2 to affect mitochondrial energy metabolism has already been described, 11, 12 the mechanisms whereby mitochondrial physiology changes control apoptosis remains to be defined.
Bid is a widespread proapoptotic factor that belongs to a subset of the Bcl-2 family, and possesses sequence homology only within the conserved BH3 domain. 13 Bid has attracted increasing interest since it was identified as a substrate of caspase 8, following the activation of death receptors such as Fas. During apoptosis, cleavage near its N-terminus by caspase-8 14, 15 produces p15 tBid, the active form of Bid, which can rapidly translocate to mitochondria and trigger cytochrome c release. 16 Truncated Bid (tBid) is 10-fold more affine for Bcl-XL than full-length Bid and is also 100 times more effective in releasing cytochrome c from mitochondria.
It was also reported that tBid interacts with mitochondrial contact sites by a specific interaction with cardiolipins 17, 18 and is able to induce remodelling of the mitochondrial membranes. 19, 20 The recent observation that tBid stimulates unravelling of the mitochondrial cristae and enhances the mobilization of cytochrome c 19 indicates that the early events affecting mitochondrial structure and function are linked to the insertion of tBid into the mitochondrial membrane. 19 Despite the increasing knowledge on the mechanisms of tBid interaction with mitochondria, the consequences of this interaction on mitochondrial bioenergetic properties have not been elucidated.
The present study analyzes the consequences of tBid interaction with mitochondrial contact sites, and the mechanism by which tBid alters the bioenergetic properties of mitochondria. Using mitochondria isolated from wild-type cells, we demonstrated for the first time that tBid acts independently of Bak and Bax to slightly increase state-4 respiration as a result of uncoupling. Moreover, tBid inhibited ADP-stimulated respiration. Both these effects do not require the BH3 domain of tBid in the first place. We also report that Bcl-2 and Bcl-XL protect mitochondria from these changes via direct interaction between their hydrophobic pocket and the BH3 domain of tBid. We therefore showed that tBid inhibits ADP-stimulated respiration by indirect inhibition of the activity of the adenine nucleotide translocator (ANT), mediated by cardiolipin reorganization into the mitochondrial inner membrane.
We also proved in this paper that the absence of cardiolipin (and consequently cardiolipin derivatives) in a cardiolipinsynthase-deficient yeast consistant with our observations, abolished subsequent effects of tBid. These results are based on biophysical approaches, showing that cardiolipins are required for tBid interaction with synthetic lipid monolayers. We finally showed that tBid triggered cytochrome c release from the mitochondrial intermembrane space in part by transient mitochondrial permeability transition pore (PTP) opening and also by a mitochondrial membrane permeabilization insensitive to cyclosporine A (CSA). This mitochondrial membrane permeabilization is probably due to membrane rigidification linked to tBid/cardiolipin relationship primarily at the contact sites with a subsequent action onto cardiolipin reorganization throughout the whole inner mitochondrial membrane.
These findings demonstrate that tBid plays a primary role in the mitochondria-mediated apoptosis pathway by disturbing mitochondrial bioenergetics. This may be a key event in predisposing mitochondria to the synergistic effect of tBid with Bax and Bak.
Results

Mitochondrial bioenergetics: basic properties
Throughout this work, we used Percoll-purified liver mitochondria from C57/Bl6 wild-type (WT) mice, transgenic mice that overexpress Bcl-2 30 or Bcl-XL, 31 and BAX À/À and BAK À/À mice. First, we investigated the basic bioenergetic properties of these mitochondria by monitoring succinate-oxidizing mitochondria. In particular, the oxidation rate (V oxidation ), respiratory control (RC), ADP/O ratio, mitochondrial membrane potential (DC m ), and phosphorylation rate (V phos. ) were analyzed as well as the basic conditions for PTP opening (in terms of large amplitude swelling' (Figure 1 ). Each parameter was obtained from the simultaneous measurement of oxygen consumption, TPP þ concentration and pH. A typical trace control (control mitochondria) is represented in Figure 2a . Figure 1a shows all steps of oxidative phosphorylation via three blocks of reactions, V oxidation , V phosphorylation and proton leaks, linked by the protonmotive force, the common thermodynamic intermediate (Dp). 35 Once added into the respiratory medium, the mitochondria began to oxidize succinate and build up a membrane potential by the proton-pumping activity of the respiratory complexes, at a high value associated with state-4 respiration. The addition of limited amounts of ADP (200 mM) induced phosphorylation-coupled respiration (state-3 respiration) and proton influx via the ATP synthase F 0 channel, leading to depolarization and a higher oxidative rate of around 71 nmol O 2 /min/mg protein (Figure 1b ). In the case of control mitochondria, DC m in state 4 (DC m 4) was around À174 mV. The respiratory control ratio (RC), which corresponds to the ratio of the respiratory rate of the phosphorylation state ðV ox3 Þ to unphosphorylation state ðV ox4 Þ, reflects the coupling of the mitochondria. Under our experimental conditions (in the presence of succinate and AP5A, i.e. P1,P5-di(adenosine-5')pentaphosphate, an inhibitor of kinase adenylate), the RC is normally over 4.5. The phosphorylation yield, ADP/O, is around 1.5 for succinate-oxidizing mitochondria.
Despite showing similar RC and ADP/O, Bcl-2-or Bcl-XLdisplaying mitochondria exhibit a higher oxidation rate associated with an increase in the phosphorylation rate (Figure 1b) . The ability of Bcl-2-or Bcl-XL-containing mitochondria to phosphorylate ADP at a faster rate may be linked to their enhanced capacity to exchange ADP/ATP. 37 Bcl-XL acts similarly during a metabolic arrest induced by growth factor withdrawal. 27 Under these conditions, Bcl-XL may allow growth factor-deprived cells to maintain sufficient ADP/ATP exchange to sustain coupled respiration.
Moreover, Bcl-2 and Bcl-XL mitochondria are less sensitive to Ca 2 þ -induced PTP opening as revealed by the increasing dose of Ca 2 þ required to induce CsA-sensitive swelling ( Figure 1c) . Our results are consistent with a previous report in which Bcl-2 potentiates maximum calcium uptake capacity in neuron-derived mitochondria. 43 The calcium concentrations required to induce swelling of liver mitochondria are similar to those in neural cell mitochondria. The enhanced ability of mitochondria from Bcl-2 and Bcl-XL-overexpressed cells to sequester large quantities of Ca 2 þ without any profound respiratory impairment provides a plausible explanation for the mechanism by which Bcl-2 and Bcl-XL inhibit certain forms of cell death.
On the other hand, the absence of Bax or Bak has no effect on mitochondrial bioenergetics. Indeed, Bax À/À or Bak þ / þ mitochondria exhibited bionergetic properties similar to control WT mitochondria (Figure 1b ).
tBid disturbs mitochondrial bioenergetics: a process independent of Bax and Bak but inhibited by Bcl-2 and Bcl-XL
We determined the action of recombinant tBid on mitochondrial bioenergetic parameters by adding tBid in wild-type succinate-oxidizing mitochondria after a first transition of phosphorylation ( Figure 2b Figure 2b , tBid acted in a timedependent manner. The inhibition in state-3 respiration and phosphorylation increased with time and marked 30% inhibition after 10 min incubation with tBid ( Figure 2b ). Inhibition of both ADP-stimulated respiration and phosphorylation rate also increased after a second ADP addition and reached 60% inhibition after 30 min (not shown). Three hypotheses could explain these inhibitions: (i) tBid might inhibit the respiratory chain (generator of proton gradient) but this hypothesis is inconsistent with the finding that tBid has no effect on the mClCCP-uncoupled respiration rate (Figure 2b ), (ii) tBid may affect the machinery of phosphorylation (consumer of proton gradient) or (iii) tBid may cause increase in proton leaks by one way or another leading to a decrease in proton gradient.
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As shown in Figure 2c -e, tBid is unable to disrupt any bioenergetic parameters (DC m , respiration and phosphorylation rate) in Bcl-2-and Bcl-XL-expressing mitochondria. Indeed, Bcl-2 and Bcl-XL completely protect mitochondria from tBid even after 10 min incubation. On the other hand, injecting a noncytotoxic dose of tBid BH3 peptide (1-5 mM) together with tBid completely restored the effect on tBid in Bcl-2 and Bcl-XL mitochondria. The same results were obtained using BH3 peptide derived from Bax or Bak (data not shown).
Our results suggest that Bcl-2 and Bcl-XL protect mitochondria from bioenergetic alterations through the interaction with the BH3 domain of tBid. We therefore investigated the effects of BH3 mutation on tBid-induced alterations of mitochondrial physiology. To this end, we used the tBid mutant mIII (tBidG94E), which is unable to interact with either proapoptotic (Bax and Bak) or antiapoptotic (Bcl-XL and Bcl-2) proteins. Adding 10 nM of mutant tBid mIII inhibited ADP-stimulated respiration to the same level in control mitochondria as tBid (Figure 2f ), suggesting that the interaction of tBid with other apoptotic factors like Bax or Bak is not required for inhibition of ADP-stimulated respiration.
Moreover, the effect of tBid mIII was maintained in Bcl-2 and Bcl-XL mitochondria and in mitochondria purified from bax À/À and bak À/À mice ( Figure 2g ). Taken together, these results show that tBid can disturb mitochondrial bioenergetics independently of Bax and Bak at least during the time of its primary action, and that Bcl-2 and Bcl-XL protect mitochondria by interacting with the BH3 domain of tBid.
tBid and tBid IIIm localize at the mitochondrial membrane level and induce a delayed conformational change and oligomerization of Bak in vitro
The treatment of Percoll-purified mitochondria with tBid and the irreversible cross-linker BMH for 30 min revealed that the BMH shifted Bak into distinct complexes of approximately 48 kDa (major species), and 72 kDa (minor species) and a 96 kDa band (not observed on these gels) (Figure 3a) . These shifted bands did not appear before 30 min incubation with tBid or if the tbid IIIm was used instead of tBid, consistent with the inability of tBid IIIm to interact with Bak. Figure 3b (lower panel) demonstrated that tBid and tBid IIIm colocalized to the mitochondrial compartment, whereas tBid lacking the alpha helices H6 and H7 did not. The upper panel corresponds to the fluorescence spectrum of EYFP (empty vector) or CMXRos (mitochondrial membrane potential measurements).
tBid inhibits ADP-stimulated respiration as a result of the inhibition of the ADP/ATP exchange Mitochondria incubated with tBid (10 nM) (Figure 4a ) or with atractyloside for 45 min (Figure 4b ) displayed a similar level of inhibition of ADP-stimulated respiration, suggesting that inhibition of the phosphorylation machinery (ANT in this case) may be responsible for the tBid effect. The time required for the insertion of tBid into the mitochondrial membrane and its stabilization may explain why complete inhibition occurred only after 45 min, although the initial action on the mitochondrial respiratory activity in the presence of ADP was detectable almost immediately (3-5 min, Figure 2b ). Incubation of mitochondria with exogenous cytochrome c did not change mitochondrial respiration inhibition by tBid, therefore demonstrating that the inhibition is not due to an early cytochrome c release (Figure 4c) .
We investigated the effect of tBid on ADP/ATP exchange in control mitochondria and in purified mitoplasts in order to exclude a possible involvement of the porin VDAC in this process (Figure 4d , e). tBid and tBid IIIm caused a significant reduction in ATP/ADP exchange in both control mitochondria and mitoplasts (around 50%), demonstrating that tBid is able to partially inhibit ADP/ATP exchange by inhibiting the ANT (Figure 4e ). This is associated with an increase in the K m for ADP (decrease in affinity) and a decrease in the V max of the ATP/ADP exchange (decrease in activity), characterizing an inhibition known as mixed or noncompetitive. This suggests that tBid affects both the ADP binding and the catalytic site of the ANT translocator. Also, consistent with our previous results, 37 ATP/ADP exchange is increased by 40% in Bcl-2 or Bcl-XL mitochondria (Figure 4e ). Since components of the outer mitochondrial membrane are not involved in this process, these results suggest that tBid may have direct access to the vicinity of the ANT, consolidating the hypothesis that tBid is able to interact directly at the contact sites by specific interaction with cardiolipin. 17 tBid interacts specifically with cardiolipin and stabilizes artificial lipid monolayer into microdomains
To elucidate the role of cardiolipin in this process, we determined the action of recombinant tBid in Dcrd1, a yeast strain deficient in cardiolipin due to a disruption of CRD1, the structural gene encoding cardiolipin synthase. First, we compared mitochondrial function in the Dcrd1 mutant and the isogenic wild type (Table 1) . Dcrd1 mutant displayed a slight decrease in the mitochondrial function. In fact, absence of cardiolipin induced an increase in the oxidation rate in state 4 associated with a decrease in state 3, associated with inhibition of ATP production, hence decreasing RC from 5.1 to 1.6. Nevertheless, the effect of tBid on the bioenergetic functions of Dcrd1 mitochondria was studied.
Incubation (Table 1) . Indeed, after a 45-min incubation, ADP-stimulated respiration inhibition increased by 76% coinciding with complete inhibition of ATP production (Figure 5c ). No effect on state-4 respiration was obtained in yeast. Since yeast is deficient in proapoptotic Bcl-2 family proteins, these results confirm our previous observation that tBid is able to disturb mitochondrial function independently of Bax and Bak. None of these changes were observed in the cardiolipin null-mutant yeast ( Table 1 and Figure 5c ) even after 45 min of incubation with tBid. We also asked whether cardiolipin was only required for tBid binding or whether it was also involved in the inhibition of ANT by tBid. Monolayers of zwitterionic PC and negatively charged cardiolipin were spread at an initial surface pressure of 20 mN/m. Injection of tBid beneath them resulted in a large increase in surface pressure only in the presence of CL and as a function of the amount of tBid injected into the subphase (Figure 5d) . Moreover, the increase in pressure was correlated with the amount of cardiolipin in the monolayer. This biophysical approach shows that cardiolipins are essential for tBid binding. tBid is only inserted in the presence of cardiolipins, and the binding efficiency is optimized when the monolayer contains approximately 25% cardiolipin, which corresponds to the natural composition of the mitochondrial inner membrane.
We also investigated the consequences of tBid-cardiolipin interaction on the phospholipid organization by epifluorescence microscopy. Figure 5e shows a set of images recorded at different times following injection of tBid into the subphase buffer. The pure cardiolipin monolayer gave a uniform fluorescent liquid-expanded phase before tBid insertion (t ¼ 0). Once tBid was added, transition to the liquidcondensed phase occurred, as indicated by the appearance of dark probe-excluded domains. These domains had a relatively homogeneous appearance after 15 min, and were distributed uniformly throughout the visual field (Figure 5e ). Thus, tBid interacts specifically with cardiolipin and stabilizes the artificial lipid monolayer into microdomains. Modification of cardiolipin organization into microdomains at the mitochondrial level may affect the function of the proteins inserted into such membranes (like ANT) and could thus lead to a decrease in ADP/ATP translocator activity. , mitochondria were preincubated with atractyloside (50 mM final) prior to transfer into the glass vessel (hatched line) and could be compared to the untreated sample (black line). The reaction was incubated for 10 min at 251C. In (c), mitochondria from mice liver control treated with or without cytochrome c are shown. An amount of 80 mg of horse cytochrome c was added to the aliquots of 150 ml reaction mixture containing mitochondria with 10 nM tBid prior to adding the mixture into the glass vessel. In (d), the effect of tBid on isolated mitochondria is shown. Mitochondria from mouse liver (control, Ctrl) or preincubated with recombinant tBid protein (1 mg tBid per 10 mg mitochondrial protein in 500 ml buffer) were loaded with 3 H-labelled ATP, washed and incubated with variable doses of nonradioactive ADP, followed by the determination of ATP release into the mitochondrial supernatant. An experiment with Bcl-2 purified mitochondria is also present as a control of the acceleration of the ADP/ATP translocation in these conditions. (e) Comparison between the effects of 10 nM tBid or 10 nM tBid G94E mutant IIIm on control mitochondria versus purified mitoplasts. Also, comparison with Bcl-2 and Bcl-XL mitochondria is shown (Figure 6a ). Moreover, even at 10-30 min, when there is an increased release of entrapped calcein, a significant release of cytochrome c is not seen (Figure 6c and d) . This late event of cytochrome c release is partly inhibited by CsA (Figure 6b ), suggesting a partial involvement of PTP in this process. Moreover, the tBid IIIm mutant was also able to release cytochrome c to a similar extent (Figure 6b and d) . The BH3 domain appears not to be involved in the long-lasting cytochrome c-releasing activity of tBid.
It was reported that a low concentration of tBid (1 nmol/mg protein) failed to induce swelling and immediate depolarization of mitochondria, 19, 38, 39, 44 whereas a small depolarization, which requires a longer incubation time, was reported (i.e., 60 min). 19 We show in this report that a higher concentration of tBid (10 nM) induced a small but significant depolarization (5-10 mV) (Figure 2b ) but not swelling (data not shown). However, PTP opening can either be associated 45 or not with a drop in DC m and/or mitochondrial swelling. 46 These transient openings can be measured by monitoring the release of calcein trapped in the mitochondrial matrix. 47 tBid increased the release of calcein from the matrix in a timedependent manner (Figure 6e) , an event only partly inhibited by the PTP pore inhibitors CsA and BA. Similar results were obtained using the BH3 mutant, Bid IIIm (G94E) (Figure 6f ), whereas Bcl-2 and Bcl-XL mitochondria were both completely insensitive to tBid. Bid IIIm (G94E) released calcein despite the presence of Bcl-2 and Bcl-XL (Figure 6g (Figure 6a and b) .
Concerning the possible involvement of the PTP in the tBid effect, we tested the effects of CsA on the mitochondrial respiration in the presence of tBid or tBid IIIm. No effect of CsA either on the state-3 inhibition or on the slight increase in state-4 respiration, which has been described (Figure 2b . In (c) and (d), time course (on 60 min) of cytochrome c release versus calcein release in the presence of 10 nM tBid and tBid IIIm, respectively, is shown. The gray zone represents the time where the cytochrome c release and the PTP pore is in a range of importance; above this zone event if the calcein release is significant, the cytochrome c release does not reach a significant level. In (e), the effects of CsA (1 mM) and BA (5 mM) on tBid-induced calcein release are shown. Mitochondria were incubated without (buffer, open circles) or with tBid (solid circles); BA (solid triangles) or CsA (red stippled circles) were added in some cases. Mitochondria were preincubated with CsA or BA for 2 min. Data are the means of five independent experiments. An amount of 5 nM tBid was used in all experiments. In (f), same as for (c), tBID IIIm (10 nM) (red stippled circles) with tBid is used (solid circles) as a control red stippled circles. CsA inhibition of calcein release. In (g), influence of Bcl-2 and Bcl-XL on tBid and tBid IIIm-induced calcein release. Solid circles: tBid (10 nM) on Bcl-2 mitochondria; stippled circles; Bcl-XL mitochondria. The effect of tBid IIIm (10 nM) on Bcl-2 (yellow closed circles) and Bcl-XL (yellow triangles) mitochondria is shown Destabilization of mitochondrial bioenergetics by truncated Bid F Gonzalvez et al (Figure 6e and f), suggesting that another type of membrane permeability, which is CsA-insensitive, should be taken into account. Such permeability might be related to reorganization of the mitochondrial membrane cardiolipin during its interaction with tBid or tBid IIIm.
Discussion
Scorrano et al. 19 recently demonstrated that tBid induces a remodelling of mitochondrial structure in vitro leading to unravelling of the cristae and exposure of cytochrome c. This reorganization event does not require the BH3 domain of tBid and is independent of Bak and slightly inhibited by CsA.
We show here for the first time that the binding of tBid to mitochondrial membrane immediately perturbs mitochondrial respiratory function. tBid is able to inhibit ADP-stimulated respiration and phosphorylation rate, independently of Bak and Bax, in mice and yeast mitochondria.
Our results, obtained with lipid monolayers, showed that cardiolipins are essential for tBid binding and raised the question as to how tBid interact with the contact sites, since cardiolipins are located in the inner membrane. The remodelling of the cristae 19 and our results describing bioenergetics mitochondrial perturbations, which take place in a similar time scale, strongly suggest that tBid has an effect on the inner membrane. Moreover, tBid may bind to the contact sites 17, 18 and disrupt the membrane curvature. 20 At the contact sites, cardiolipins and phosphatidylethanolamines adopt a hexagonal H II configuration, 21, 22 so that over 45% of the endogenous phospholipids at the contact sites can adopt a nonbilayer configuration. It is evident that because of their unique chemical structure and the relative polymorphic phase behavior, cardiolipins have easy access to the outer mitochondrial membrane. 23, 24 Cardiolipins at the contact site might be accessible to tBid. tBid may interact with contact sites and induce the reorganization of phospholipids into microdomains (especially cardiolipin). Specific binding of cardiolipin to the ADP/ATP translocator has already been reported and the monitoring of reconstituted carrier activity has revealed that this interaction is required for its activity. 25, 26 It is conceivable that tBid indirectly influences the activity of ANT by redistributing phospholipids.
The observed transient PTP opening induced by tBid seems to be coordinated with remodelling of the cristae, mobilization of cytochrome c stores from the cristae, and the final release of cytochrome c due to permeabilization of the outer membrane, three events partly inhibited by CsA and BA. 19 We demonstrated that tBid and tBid IIIm colocalized at the mitochondrial membrane but while tBid interacts with Bak, tBid IIIm did not. 27 We also showed that the deletion of the H6H7 alpha helices totally abolished both tBid and tBid IIIm targeting to the mitochondria. The experiment using Bid IIIm (G94E) and tBid BH3 provides the first evidence that the BH3 domain of tBid is involved neither in the disruption of mitochondrial bioenergetics nor in cytochrome c release.
We believe that our results reinforce the recent discovery of the changes in mitochondrial structure induced by tBid, 19 an observation made at the same time scale (15-20 min) . These results are in direct line with the observation that tBid induces Bax and Bak oligomerization at the mitochondrial membrane. 28 Based on these observations, we propose a two-step model ( Figure 7 ) in which tBid plays a primary role in destabilizing mitochondrial membrane structure and function. This function of tBid relates to its ability to bind cardiolipin, and to enhance the delocalization of Bax (or Bak) from the cytoplasm to the mitochondrial membrane, their oligomerization, and consequently contributes to the amplification of the mitochondrial damage, which culminates with cytochrome c release.
Materials and Methods
Materials
All chemicals and supplies were obtained from Sigma (St. Louis, MO, USA) unless otherwise stated. Full-length His-tagged mouse Bid, wild-type and mutants, were purified as described by Desagher et al. 29 We used tBid stock solutions (1.9 mg/ml) diluted in nM dose in the respiratory buffer. The buffer alone has no effect on mitochondrial parameters.
Peptides were synthesized on a Rainin Symphony synthesizer using a standard SPPS (solid phase peptide synthesis) method (Novabiochem). 15 Bid BH3 peptide was synthesized with the following sequence RNIARHLAQVGDSMDR and was used at nontoxic concentrations (less than 5 mM). The toxicity of the Bid-BH3 peptide has been tested on purified mitochondria bioenergetics with the same protocol as for tBid (see below).
Animals
Studies were performed on 6-12-week-old mice (control [C57/Bl6]) and age-and sex-matched congenic mice expressing a Bcl-2 30 or Bcl-XL transgene 31 under the L-type pyruvate kinase gene promoter and on Bax À/À and Bak À/À mice (kindly provided by CB Thompson and S Korsmeyer, USA).
Purification of mouse liver mitochondria and mitoplasts
Mice were killed by decapitation and their livers removed and placed in cold medium H (pH 7.2) containing 0.3 M sucrose, 5 mM TES, 0.2 mM EGTA, and 0.1% BSA (w/v). Mitochondria were isolated by classical differential centrifugation to obtain a crude mitochondrial preparation. 32 The crude mitochondria were layered on a Percoll gradient (10 min at 8500 Â g) consisting of three layers (18, 30 Oxygen uptake, membrane potential, rate of phosphorylation and large amplitude swelling Purified mitochondria were resuspended in respiratory medium (R) consisting of 100 mM KCl, 40 mM sucrose, 5 mM MgCl 2 , 10 mM TES, 10 mM KH 2 PO 4 (pH 7.2), 1mM EGTA and 0.1% BSA. The mitochondrial protein concentration used for measurement was 0.333 mg/ml (in a 3 ml cuvette). The mitochondrial respiration rate (V ox ) and membrane potential (DC m ) were monitored by the simultaneous use of a Clark-type electrode, a tetraphenylphosphonium cation-sensitive electrode (TPP þ ) and a pHelectrode, at 251C in medium R. Membrane potential was calculated according to Kamo et al. 33 and the TPP þ binding was corrected according to Rottenberg. 34 The phosphorylation rate was estimated from the H þ influx, estimated by pH changes, and each curve was calibrated with increasing amounts of 0.1 N HCl. 35 The swelling of mitochondria was estimated from the decrease in absorbance measured at 520 nm in a Cary 50 spectrophotometer (Varian SA, Australia) in hypotonic swelling medium S (250 mM sucrose, 5 mM Tris-MOPS, 0.3 mM KH 2 PO 4 , 0.5 mg/ml oligomycin, 5 mM succinate and 2 mM rotenone at pH 7.2). Inorganic phosphate (250 mM) was added to ensure optimal succinate transport and subsequent succinate dehydrogenase activity. Trace amounts of EGTA (10 mM) ensured good experimental reproducibility without affecting the pore opening. Mitochondria from control or transgenic mice were incubated in medium S (0.33 mg/ml), treated with 5 mM atractyloside (plus low concentrations of Ca 2 þ (100 mM) for preconditioning), or terbutyl-hydroperoxide (50 mM), or calcium 300 mM.
In vitro assay of cytochrome c release and calcein release
Purified mouse liver mitochondria were resuspended in medium R (pH 7.2). An amount of 5 ml of isolated mitochondria (stock concentration 25 mg/ml) was mixed by gentle stirring with the indicated amount of proteins or compounds plus 4 ml of protease inhibitors cocktail (Sigma) in a final volume of 50 ml medium S for 30 min at room temperature. Mitochondria were then collected by centrifugation at 12 000 Â g for 5 min at 41C and the supernatants were analyzed by 15% SDS-PAGE and using a mouse monoclonal anti-cytochrome c antibody (Pharmingen, clone 7H8.2C12).
For calcein release, mitochondria suspended in respiration medium (R) without BSA were loaded with 10 nM calcein-AM (Molecular Probes) for 20 min at room temperature in the dark. Following two washes, 0.5 mg/ml calcein-loaded mitochondria were incubated in a calcein measurement medium (125 mM KCl, 10 mM tris-MOPS (pH 7.4), 1 mM Pi, 5 mM succinate, 10 mM EGTA-Tris (pH 7.4), a concentration which does not block the PTP opening but ensures reproductivity to the measurements) and treated as described in the Figure 5 . After the indicated time, mitochondria were spun down. Calcein was measured in the spin down supernatant in an LS-50B spectrofluorometer (Perkin-Elmer) with excitation and emission wavelengths set at 48872.5 and 54272.5 nm, respectively. Calcein release is reported as the percentage of the calcein measured in the supernatant over the total (pellet þ supernatant).
ATP/ADP translocase activity in purified mitochondria
Percoll-purified liver mitochondria (from female, 6-12-week-old C57/Bl6 mice and age-and sex-matched congenic mice) were suspended (10 mg protein per 500 ml) in 0.6 M mannitol, 0.2% BSA, 10 mM MOPS, and 0.1 mM EDTA (pH 6.8). For kinetic analyses of ADP/ATP exchange, we modified the method developed by Pfaff et al. 36 Purified mitochondria were incubated with 15 ml [2, H] ATP (40 Ci/mmol) at 41C after a preincubation of 45 min in the presence or absence of tBid. They were then washed twice to eliminate free [2, H] ATP. Exchange was initiated by adding cold ADP (400 mM) and stopped after 10 s by adding 100 mM atractyloside and centrifugation (6800 Â g, 10 min, 41C). 37 
Recombinant proteins and coimmunoprecipitation
IVT proteins were transcribed in vitro and translated as described by Wei et al, 38 whereas recombinant tBid or tBidIIIm were either purified as described by Wei et al. 38 or as described by Desagher et al.
29
35 S-labelled IVT proteins were incubated with Percoll-purified mouse liver mitochondria for various periods of time (10-30 min) at 301C. The mitochondria were then solubilized and incubated with anti-Bak antibody for 1 h at 41C as described by Wei et al. 38 The beads were then analyzed by fluorography for bound proteins.
Yeast cell mitochondria
Wild-type yeast strain and the cardiolipin synthase-deficient strain WKEN011A 39 were grown aerobically at 281C in complete medium (1% yeast extract, 0.12% ammonium sulfate, 0.1% potassium phosphate, 2% DL-lactate, pH 5.2) until the mid-exponential growth phase. Cells were harvested and mitochondria were isolated as described previously. 40 Mitochondria were suspended at 0.17 mg/ml in 10 mM Tris-maleate buffer (pH 6.8) containing 0.6 M mannitol and 2 mM EGTA. Respiration rates were measured at 281C in the presence of 5 mM potassium phosphate, 1 mM NADH and 50 mM ADP (state 3). Mitochondria were preincubated with tBid for the indicated time periods. ATP synthesis was measured in the presence of 1 mM ADP with 1 mM NADH as substrate, and in the presence of AP5A 13 mg/ml, an inhibitor of the adenylate kinase. Samples (150 ml) were removed at 0, 10, 20 and 30 s after adding ADP. Proteins were precipitated by adding 50 ml 7% perchloric acid in 50 mM EDTA and the samples cleared by centrifugation. Aliquots (150 ml) of supernatant were neutralized by adding 24 ml 0.3 M MOPS/2 N KOH, and ATP was measured with a luciferin/luciferase kit (Bio-orbit) in an LKB bioluminometer. Rates of ATP synthesis were calculated from linear regression plots of ATP produced versus time.
Biophysical measurements on lipid monolayers
All monolayer experiments were carried out in Teflon dishes at 221C. Monolayers of pure or mixed phospholipids were spread on a subphase buffer (5 mM Tris-HCl, pH 7.5 and 150 mM NaCl) to give an initial surface pressure of 20 mN/m. tBid was added to the stirred subphase. The pressure changes were monitored until the increase in surface pressure was maximal.
Epifluorescence observations were made with an Olympus-BX30 microscope. The fluorescent probe 1-palmitoyl-2{6[(7-nitro-2-1,3-benzoxadizol-4-yl)amino]dodecanoyl} phosphatidylglycerol (NBD-PG, purchased from Avanti Polar Lipids Inc., USA) was excited at 470 nm using a mercury lamp and its emission recorded at 530 nm. Mixtures were prepared from a chloroform solution of DPPC containing the desired proportions of cardiolipin and 0.5 mol% NBD-PG. This hydrophilic probe is excluded from densely packed areas of lipid, providing contrast between lipid phases.
Microspectrofluorometric analysis
Microspectrofluorometric analysis was performed under epi-illumination conditions by means of Zeiss UMSP 80 confocal microscope equipped with an UV-visible argon laser and an optical multichannel analyzer (OMA III with an IRY 1024/6B from Princeton Applied Research). The acquisition system and data treatment were carried out with a Prism system (Jobin & Yvon). The excitation was set at 488 nm and the spectra were recorded in the 540-750 nm range. The size of the area where the spectra are recorded is 0.8 mm. The spectra of EYFP (empty vector from BD Bioscience, USA, cytoplasmic) and of the mitochondrially localized CMXRos (Chloromethyl-X-Rosamine, Molecular Probes, USA) are presented in Figure 3b as references. CMXRos was added to the cells at a final concentration of 20 nM (preincubation time 15 min at room temperature).
